BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38193393)

  • 1. Synthesis and Preliminary Study of
    Ma M; Yang G; Zhao M; Liu Y; Ge X; Jia B; Gao S
    Mol Pharm; 2024 Feb; 21(2):735-744. PubMed ID: 38193393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of [
    Jia X; Li X; Jia B; Yang Y; Wang Y; Liu Y; Ji T; Xie X; Yao Y; Qiu G; Deng H; Zhu Z; Chen S; Yang A; Gao R
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1228-1239. PubMed ID: 36477400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Bioevaluation of
    Ruan Q; Feng J; Jiang Y; Zhang X; Duan X; Wang Q; Yin G; Xiao D; Zhang J
    Mol Pharm; 2022 Jan; 19(1):160-171. PubMed ID: 34904839
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Liu Y; Zhang Q; Zhang Y; Wang J; Wu Y; Yang G; Shi J; Wang F; Xu Z; Jing H
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel
    Ruan Q; Zhou C; Wang Q; Kang F; Jiang Y; Li G; Feng J; Zong S; Zhang J; Wang J
    Mol Pharm; 2023 Jun; 20(6):2942-2950. PubMed ID: 37083360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.
    Luo X; Zhang Z; Cheng C; Wang T; Fang D; Zuo C; Yuan G; Li R; Li X
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel molecular imaging probe [
    Jiang Y; Tian Y; Feng B; Zhao T; Du L; Yu X; Zhao Q
    Sci Rep; 2023 Mar; 13(1):3700. PubMed ID: 36879039
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Boschi A; Urso L; Uccelli L; Martini P; Filippi L
    EJNMMI Radiopharm Chem; 2024 May; 9(1):36. PubMed ID: 38695960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
    Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and Preclinical Assessment of
    Trujillo-Benítez D; Luna-Gutiérrez M; Ferro-Flores G; Ocampo-García B; Santos-Cuevas C; Bravo-Villegas G; Morales-Ávila E; Cruz-Nova P; Díaz-Nieto L; García-Quiroz J; Azorín-Vega E; Rosato A; Meléndez-Alafort L
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X; Li G; Ruan C; Hu K; Tang G
    Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.
    Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H
    J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of
    Ruan Q; Wang Q; Jiang Y; Feng J; Yin G; Zhang J
    J Med Chem; 2023 Apr; 66(7):4952-4960. PubMed ID: 36972467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer
    Shi J; Du S; Wang R; Gao H; Luo Q; Hou G; Zhou Y; Zhu Z; Wang F
    J Transl Med; 2023 Jan; 21(1):19. PubMed ID: 36631812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
    Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.